AGM results: all 11 resolutions passed, Re 1 dividend approved
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
27th AGM held on Sept 17, 2026 via video conferencing. All 11 resolutions passed with about 98.55 percent votes in favour. Final dividend of Re 1 per equity share of Rs 10 face value approved for FY ended March 31, 2026. M/s A D V and Associates appointed as Statutory Auditors. Mrs Namrata Modi re-appointed as Whole-Time Director and Mr Sai Kalyan Surapaneni re-appointed as Executive Director. Three independent directors appointed regularized by Piyush Gupta, Abhijeet Haridas and Sukhen Babuta. Waiver of recovery of excess managerial remuneration paid to Executive Director for FY 2024-25 and 2025-26 also approved with 98.53 percent support.
Routine AGM outcome with strong shareholder backing. Dividend declared, board continuity maintained, and new auditors and independent directors confirmed.